Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
US10920189B2 · kind B2 · utility
5Cited by
65References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2020 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Jun 18, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/19
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.